Cargando…

Immunotherapy of COVID-19: Inside and Beyond IL-6 Signalling

Acting on the cytokine cascade is key to preventing disease progression and death in hospitalised patients with COVID-19. Among anti-cytokine therapies, interleukin (IL)-6 inhibitors have been the most used and studied since the beginning of the pandemic. Going through previous observational studies...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zizzo, Gaetano, Tamburello, Antonio, Castelnovo, Laura, Laria, Antonella, Mumoli, Nicola, Faggioli, Paola Maria, Stefani, Ilario, Mazzone, Antonino
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8948465/ https://www.ncbi.nlm.nih.gov/pubmed/35340805 http://dx.doi.org/10.3389/fimmu.2022.795315

Ejemplares similares

Monocytes could be a bridge from inflammation to thrombosis on COVID-19 injury: A case report
por: Mazzone, Antonino, et al.
Publicado: (2020)

Anti-IL6 treatment of serious COVID-19 disease: A monocentric retrospective experience
por: Castelnovo, Laura, et al.
Publicado: (2021)

Assessing SARS-CoV-2-specific T-cell reactivity in late convalescents and vaccinees: Comparison and combination of QuantiFERON and activation-induced marker assays, and relation with antibody status
por: Gatti, Arianna, et al.
Publicado: (2023)

Schnitzler syndrome, a rare autoinflammatory disease. Complete response to IL-1 blockade
por: Faggioli, Paola, et al.
Publicado: (2017)

Iloprost in COVID-19: The Rationale of Therapeutic Benefit
por: Faggioli, Paola Maria, et al.
Publicado: (2021)

Interstitial Lung Disease in Rheumatoid Arthritis: A Practical Review
por: Laria, Antonella, et al.
Publicado: (2022)

Amiodarone-induced organizing pneumonia mimicking COVID-19: a case report
por: Zizzo, Gaetano, et al.
Publicado: (2021)

Good’s syndrome, a rare form of acquired immunodeficiency associated with thymomas
por: Tamburello, Antonio, et al.
Publicado: (2019)

Improvement of HbA1c in Patients with Type 2 Diabetes Mellitus and Rheumatoid Arthritis Treated with bDMARDs
por: Lurati, Alfredomaria, et al.
Publicado: (2021)

Reorganizing Italian Internal Medicine wards for COVID 19
por: Mazzone, Antonino, et al.
Publicado: (2020)

COVID-19-Associated Pneumonia in a B-Cell-Depleted Patient With Non-Hodgkin Lymphoma: Recovery With Hyperimmune Plasma
por: Colombo, Daniele, et al.
Publicado: (2022)

Clinical immunity in discharged medical patients with COVID-19
por: Mumoli, Nicola, et al.
Publicado: (2020)

Man with fever, cough, and weakness
por: Mumoli, Nicola, et al.
Publicado: (2020)

Cardiac injury as prognostic value in COVID-19: more remains to be clarified
por: Mumoli, Nicola, et al.
Publicado: (2020)

IL-15 in the Combination Immunotherapy of Cancer
por: Waldmann, Thomas A., et al.
Publicado: (2020)

Giant condyloma acuminatum of the perineum
por: Mumoli, Nicola, et al.
Publicado: (2021)

Superior vena cava syndrome after pacemaker implantation treated with direct oral anticoagulation
por: Mumoli, Nicola, et al.
Publicado: (2021)

The IL-17 Family of Cytokines in Psoriasis: IL-17A and Beyond
por: Brembilla, Nicolo Costantino, et al.
Publicado: (2018)

Beyond the Driver Mutation: Immunotherapies in Gastrointestinal Stromal Tumors
por: Roulleaux Dugage, Matthieu, et al.
Publicado: (2021)

Editorial: The key role of Mer receptor tyrosine kinase: where inflammation ends and fibrosis begins
por: Zizzo, Gaetano, et al.
Publicado: (2023)

Organizational Impact of the Introduction of a New Portable Syringe Pump for Iloprost Therapy in Italian Hospital Settings
por: Restelli, Umberto, et al.
Publicado: (2015)

Further Advances in Cancer Immunotherapy: Going Beyond Checkpoint Blockade
por: Wilkinson, Robert W., et al.
Publicado: (2018)

Post-COVID or long-COVID: Two different conditions or the same?
por: Mumoli, Nicola, et al.
Publicado: (2021)

Transient perivascular inflammation of the carotid artery (TIPIC) syndrome in a patient with COVID-19
por: Mumoli, Nicola, et al.
Publicado: (2021)

IL-6 signaling in macrophages is required for immunotherapy-driven regression of tumors
por: Beyranvand Nejad, Elham, et al.
Publicado: (2021)

IL-17A in Psoriasis and Beyond: Cardiovascular and Metabolic Implications
por: von Stebut, Esther, et al.
Publicado: (2020)

Respiratory Impairment Predicts Response to IL-1 and IL-6 Blockade in COVID-19 Patients With Severe Pneumonia and Hyper-Inflammation
por: Della-Torre, Emanuel, et al.
Publicado: (2021)

Combinational Immunotherapy for Hepatocellular Carcinoma: Radiotherapy, Immune Checkpoint Blockade and Beyond
por: Lee, Yun Hua, et al.
Publicado: (2020)

Targeting myeloid-derived suppressor cells in tumor immunotherapy: Current, future and beyond
por: Zhao, Yang, et al.
Publicado: (2023)

IL-15/IL-15Rα Heterodimeric Complex as Cancer Immunotherapy in Murine Breast Cancer Models
por: Guo, Siqi, et al.
Publicado: (2021)

The Meaning of D-Dimer value in Covid-19
por: Conte, Giulia, et al.
Publicado: (2021)

Inside-Out of Complement in Cancer
por: Kolev, Martin, et al.
Publicado: (2022)

Recent Advances in IL-13Rα2-Directed Cancer Immunotherapy
por: Knudson, Karin M., et al.
Publicado: (2022)

Assessment of SARS-CoV-2 Reinfection 1 Year After Primary Infection in a Population in Lombardy, Italy
por: Vitale, Josè, et al.
Publicado: (2021)

Interleukin (IL)-6 Inhibits IL-27- and IL-30-Mediated Inflammatory Responses in Human Monocytes
por: Petes, Carlene, et al.
Publicado: (2018)

Inside-Out Control of Fc-Receptors
por: Koenderman, Leo
Publicado: (2019)

Inside Rubik’s cube and beyond
por: Bandelow, Christoph
Publicado: (1982)

CD1d-Invariant Natural Killer T Cell-Based Cancer Immunotherapy: α-Galactosylceramide and Beyond
por: King, Lisa A., et al.
Publicado: (2018)

Palliative care in a COVID-19 Internal Medicine ward: A preliminary report
por: Mumoli, Nicola, et al.
Publicado: (2021)

Corrigendum: Inside-Out Control of Fc-Receptors
por: Koenderman, Leo
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_p6737jbs9ufq4himra5iciq9vb